Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



    October 5, 2018

    The Bears Reared Their Ugly Heads Today

    Today’s markets were substantially bearish. The SPY ETF traded as low as 286.22, a decline of nearly 1%, before bouncing back to recoup around 40% of its declines at the time this article was written. This negative bias affected most stocks in the healthcare and biotech sectors, with the XLV healthcare sector ETF and the […]

    Read Article
    October 4, 2018

    Mallinckrodt Pharmaceuticals Is In Need Of Its Own Medicine

    Both biotech and healthcare stocks were sharply lower overall in today’s session. Overall, US equities markets sold sharply off recent all-time highs as reality finally set in that interest rates would likely continue higher due to persistently positive economic data. One stock hit particularly hard today is Mallinckrodt (MNK), which traded down over 17.50%. Besides […]

    Read Article
    October 2, 2018

    Looks Like Another Bubble Is In the Works

    Shares of India Globalization Capital Inc. (IGC) rose sharply in overnight trading and into the early part of today’s session. The stock appears to be moving due to market-wide excitement over CBD-infused beverages, an area that IGC participates in. However, some analysts feel that the stock’s meteoric rise after nearly 10 years of declining value […]

    Read Article
    October 1, 2018

    Omeros Over-Promises and Under-Delivers

    Two stocks in the biotech/healthcare space were pummeled today after receiving negative news. First up is Omeros (OMER), which disseminated a misleading press release stating that they had additional “positive” data on their study of OMS721. However, those positive points were greatly outweighed by the fact that the study showed very little effect for the […]

    Read Article
    September 28, 2018

    IGC Had Quite A Day

    We saw another big move in IGC, India Globalization Capital, in trading today. The stock traded as high as $7.48 before retreating to under $6 per share in the latter part of the session. This stock signaled a long entry for us a few days ago at $3.25, and I expected to be in the […]

    Read Article
    September 27, 2018

    There’s Possible New Hope For Lyme’s Disease

    The stock TTOO, T2 Biosystems Inc., was bullish in trading today. The stock was up over 6% towards the end of the session, primary due to news from Wednesday that the company’s diagnostic device for identifying borrelia infections for patients suspected of having early Lyme disease was indicated to be more accurate than other existing […]

    Read Article
    September 25, 2018

    A Struggle Of A Day For the Biotechs

    There were big moves and subsequent pullbacks today for many biotech and healthcare stocks. Continuing the recent theme of inconsistent trading, most symbols struggled to maintain momentum throughout the session. AMRN, for example, was up very sharply at the open, moving up from around $12.00 to a high of $14.64, and then proceeding to give […]

    Read Article
    September 24, 2018

    The Biotechs Did Not Know Which Way To Go Today

    We saw some strong moves up and down in the biotech/healthcare space today. One example is Fibrocell Science Inc. The stock was up over 10% towards the middle of the session due to rumors of an FDA contract. However, this has yet to be confirmed. Meanwhile, Spectrum Pharmaceuticals was down nearly 20% after releasing updated […]

    Read Article
    September 21, 2018

    India Globalization Inc. Pops!

    We saw some major moves in biotech/healthcare today. India Globalization Inc. (IGC) was up over 70% at its peak today, trading above $4 after opening just above $2.50 per share. While there is no pressing news behind the move, the sector has been fairly hot lately and IGC appears to be in a good position […]

    Read Article
    September 20, 2018

    Altimmune About To Go Viral

    Shares of Altimmune Inc. (ALT) rose very sharply in trading over the last 24 hours. On the surface, it was alleged that the company’s shares rose due to positive news from its pipeline developments for its phase 1 and 2 research. However, the company recently completed a 1:30 reverse split, meaning that every 30 shares […]

    Read Article